Core Viewpoint - InspireMD, Inc. is set to present at the Bank of America 2025 Healthcare Conference, highlighting its focus on carotid artery disease treatment and stroke prevention through its CGuard™ Prime carotid stent system [1]. Company Overview - InspireMD, Inc. develops the CGuard™ Prime carotid stent system aimed at treating carotid artery disease and preventing strokes [1]. - The company utilizes its proprietary MicroNet® technology to establish its products as the industry standard for carotid stenting, emphasizing superior acute results and long-term stroke-free outcomes [2]. Event Details - The presentation at the Bank of America 2025 Healthcare Conference is scheduled for May 14, 2025, at 1:15 PM Eastern Time / 10:15 AM Pacific Time [1]. - A live audio webcast and replay of the presentation will be available for 90 days on the company's website [2].

Core Viewpoint - InspireMD, Inc. is set to present at the 24th Annual Needham Virtual Healthcare Conference on April 9, 2025, showcasing its CGuard™ Prime carotid stent system aimed at treating carotid artery disease and preventing strokes [1]. Company Overview - InspireMD, Inc. develops the CGuard™ Prime carotid stent system, utilizing proprietary MicroNet® technology to establish its products as the industry standard for carotid stenting, focusing on achieving excellent acute results and long-term stroke-free outcomes [2]. - The company's common stock is traded on Nasdaq under the ticker symbol NSPR, and it regularly updates investors through its website [2]. Event Details - The presentation will be accessible via a live audio webcast, with a replay available for 90 days on the company's website [2].